Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.
Kubota T, Okano Y, Sakai M, Takaoka M, Tsukuda T, Anabuki K, Kawase S, Miyamoto S, Ohnishi H, Hatakeyama N, Machida H, Urata T, Yamamoto A, Ogushi F, Yokoyama A.
Kubota T, et al. Among authors: urata t.
Anticancer Res. 2016 Jan;36(1):307-12.
Anticancer Res. 2016.
PMID: 26722058
Clinical Trial.